deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT04685824

Visual Telerehabilitation in AMD Patients

Visual Rehabilitation in Macular Degeneration: a Pilot Study on Biofeedback Training and Home-based Mobile Virtual-reality Stimulation

Sponsor: Michael Reber

Updated 7 times since 2021 Last updated: Nov 27, 2023 Started: Sep 15, 2021 Primary completion: Oct 6, 2023 Completion: Oct 6, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Recruitment rate not reached.

A NA clinical study on Macular Degeneration, this trial is terminated or withdrawn. The trial is conducted by Michael Reber and has accumulated 7 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Oct 2021 · 5 months · monthly snapshot~Oct 2021 – ~Oct 2023 · 24 months · monthly snapshotRecruiting~Oct 2023 – ~Dec 2023 · 2 months · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Dec 2023 — Jul 2024 [monthly]

    Terminated NA

    Status: Unknown StatusTerminated

  4. Oct 2023 — Dec 2023 [monthly]

    Unknown Status NA

    Status: RecruitingUnknown Status

  5. Oct 2021 — Oct 2023 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

Show 2 earlier versions
  1. May 2021 — Oct 2021 [monthly]

    Not Yet Recruiting NA

  2. Jan 2021 — May 2021 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Michael Reber
Data source: University Health Network, Toronto

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations